MARTIN ANGST, MD
Anesthesiologist Assistant at Pasteur Dr, Palo Alto, CA
License number
California A70346
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 723-4000
Professional information
Dr. Martin S Angst, Stanford CA - MD (Doctor of Medicine)
Specialties:
Anesthesiology, Allergy & Immunology
Address:
Stanford Office
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone)
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone)
Languages:
English
Hospitals:
Stanford Office
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Universitat Bern, Medizinische Fakultat
Graduated: 1987
University Hospital Of Berne
Stanford University School Of Medicine
Universitat Bern, Medizinische Fakultat
Graduated: 1987
University Hospital Of Berne
Stanford University School Of Medicine
Martin Stephan Angst, Palo Alto CA
Specialties:
Anesthesiology, General Practice
Work:
SHC
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
Education:
Universitat Bern (1987)
Martin Angst, Stanford CA
Specialties:
Anesthesiologist
Address:
300 Pasteur Dr, Stanford, CA 94305
Methods For Treatment Of Headaches By Administration Of Oxytocin
US Patent:
8252745, Aug 28, 2012
Filed:
Oct 7, 2011
Appl. No.:
13/269527
Inventors:
David C. Yeomans - Sunnyvale CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
Trigemina, Inc. - Mountain View CA
HealthPartners Research Foundation - Bloomington MN
Trigemina, Inc. - Mountain View CA
HealthPartners Research Foundation - Bloomington MN
International Classification:
A61K 38/11, A61K 51/00, A61P 5/10, C07K 7/16
US Classification:
514 116, 530315
Abstract:
The present invention relates to methods for the treatment of headache and headache disorders. The methods comprise administration of an oxytocin peptide for the treatment of primary and secondary headaches or trigeminal neuralgia.
Methods For Treatment Of Headaches By Administration Of Oxytocin
US Patent:
8202838, Jun 19, 2012
Filed:
Mar 23, 2009
Appl. No.:
12/409419
Inventors:
David C. Yeomans - Sunnyvale CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
Trigemina, Inc. - Mountain View CA
HealthPartners Research Foundation - Bloomington MN
Trigemina, Inc. - Mountain View CA
HealthPartners Research Foundation - Bloomington MN
International Classification:
A61K 38/11, A61K 51/00, A61P 5/10, C07K 7/16
US Classification:
514 116, 530315
Abstract:
The present invention relates to methods for the treatment of headache and headache disorders. The methods comprise administration of an oxytocin peptide for the treatment of primary and secondary headaches or trigeminal neuralgia.
Methods For Treatment Of Headaches By Administration Of Oxytocin
US Patent:
2009018, Jul 16, 2009
Filed:
Sep 15, 2008
Appl. No.:
12/210866
Inventors:
David C. YEOMANS - Sunnyvale CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
International Classification:
A61K 38/22
US Classification:
514 2
Abstract:
The present invention relates to methods for the treatment of headache and headache disorders. The methods comprise administration of an oxytocin peptide for the treatment of primary and secondary headaches or trigeminal neuralgia.
Methods For Treatment Of Headaches By Administration Of Oxytocin
US Patent:
2007005, Mar 8, 2007
Filed:
Aug 28, 2006
Appl. No.:
11/511997
Inventors:
David Yeomans - Sunnyvale CA, US
Martin Angst - Palo Alto CA, US
William Frey - White Bear Lake MN, US
Daniel Jacobs - Mountain View CA, US
Martin Angst - Palo Alto CA, US
William Frey - White Bear Lake MN, US
Daniel Jacobs - Mountain View CA, US
International Classification:
A61K 38/12
US Classification:
514009000
Abstract:
The present invention relates to methods for the treatment of headache and headache disorders. The methods comprise administration of an oxytocin peptide for the treatment of primary and secondary headaches or trigeminal neuralgia.
Methods For Evaluating The Activity Of Candidate Agents
US Patent:
2006017, Aug 3, 2006
Filed:
Jan 27, 2006
Appl. No.:
11/342246
Inventors:
David Yeomans - Stanford CA, US
Martin Angst - Stanford CA, US
Michael Peters - Stanford CA, US
Mary Peters - Hobart IN, US
Martin Angst - Stanford CA, US
Michael Peters - Stanford CA, US
Mary Peters - Hobart IN, US
International Classification:
A61K 49/00
US Classification:
424009200
Abstract:
Methods for evaluating the activity of candidate agents are provided. In practicing the subject methods, a candidate agent is administered to an injured tissue site of an animal and the activity of the candidate agent on the injured tissue site is evaluated. Also provided are kits and systems for use in practicing the subject methods.
Methods For Treatment Of Pain
US Patent:
2013019, Aug 1, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/802075
Inventors:
David C. YEOMANS - Sunnyvale CA, US
Martin S. ANGST - Palo Alto CA, US
Daniel I. JACOBS - Mountain View CA, US
Martin S. ANGST - Palo Alto CA, US
Daniel I. JACOBS - Mountain View CA, US
Assignee:
TRIGEMINA, INC. - Moraga CA
International Classification:
A61K 38/10, A61K 45/06
US Classification:
514 84, 514 184, 514 119, 514 124, 514 126, 514 103
Abstract:
The invention provides for methods and compositions for treatment of pain via craniofacial mucosal administration of an analgesic compound (e.g. a non-opioid analgesic peptide, an NOP agonist or N/OFQ). Intranasal administration of certain analgesic peptides such as N/OFQ results in global analgesic effects.
Methods For Treatment Of Pain
US Patent:
8551949, Oct 8, 2013
Filed:
Jul 27, 2010
Appl. No.:
12/844721
Inventors:
Lawrence R. Toll - Redwood City CA, US
David C. Yeomans - Sunnyvale CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
David C. Yeomans - Sunnyvale CA, US
Martin S. Angst - Palo Alto CA, US
Daniel I. Jacobs - Mountain View CA, US
Assignee:
Nocicepta LLC - Wilmington DE
International Classification:
A61K 38/10, A61K 38/00, C07K 7/08, C07K 7/00
US Classification:
514 183, 514 11, 514 214, 530300, 530326
Abstract:
The invention provides for methods and compositions for treatment of pain via craniofacial mucosal administration of an analgesic compound (e. g. a non-opioid analgesic peptide, an NOP agonist or N/OFQ). Intranasal administration of certain analgesic peptides such as N/OFQ results in global analgesic effects.